Analysis and Commentary STEVEN GROSSMAN 8/31/18 Analysis and Commentary STEVEN GROSSMAN 8/31/18 On the Physical Capabilities of a Lame Duck Read More Analysis and Commentary STEVEN GROSSMAN 8/24/18 Analysis and Commentary STEVEN GROSSMAN 8/24/18 August as Usual in DC? Definitively NOT! Read More Analysis and Commentary STEVEN GROSSMAN 8/5/18 Analysis and Commentary STEVEN GROSSMAN 8/5/18 The Full Senate Position on FDA's FY 19 Appropriation Read More Analysis and Commentary STEVEN GROSSMAN 7/13/18 Analysis and Commentary STEVEN GROSSMAN 7/13/18 Our Advocacy Remains an Imperative for Strong Funding Read More Analysis and Commentary STEVEN GROSSMAN 6/29/18 Analysis and Commentary STEVEN GROSSMAN 6/29/18 Aiming High AND Moving Quickly Read More Analysis and Commentary STEVEN GROSSMAN 6/22/18 Analysis and Commentary STEVEN GROSSMAN 6/22/18 Good Fortune Can Easily Slip Away Read More Analysis and Commentary STEVEN GROSSMAN 6/8/18 Analysis and Commentary STEVEN GROSSMAN 6/8/18 FY 19 Appropriations the Alliance Seeks to Support Read More Analysis and Commentary STEVEN GROSSMAN 6/1/18 Analysis and Commentary STEVEN GROSSMAN 6/1/18 Strong BA Support for FDA on Capitol Hill -- At Different Levels Read More Analysis and Commentary STEVEN GROSSMAN 5/24/18 Analysis and Commentary STEVEN GROSSMAN 5/24/18 FY 19 Funding: House and Senate Proposals Read More Analysis and Commentary STEVEN GROSSMAN 5/17/18 Analysis and Commentary STEVEN GROSSMAN 5/17/18 House Recommends Major Increase in BA Funding Read More Analysis and Commentary STEVEN GROSSMAN 5/11/18 Analysis and Commentary STEVEN GROSSMAN 5/11/18 The Good Start Continues ... Let's Show Appreciation Read More Analysis and Commentary STEVEN GROSSMAN 5/4/18 Analysis and Commentary STEVEN GROSSMAN 5/4/18 Additional Investment = Substantial Added Value Read More Analysis and Commentary STEVEN GROSSMAN 4/27/18 Analysis and Commentary STEVEN GROSSMAN 4/27/18 FY 19 -- Off to a Great Start Read More Analysis and Commentary STEVEN GROSSMAN 4/21/18 Analysis and Commentary STEVEN GROSSMAN 4/21/18 The Alliance's "Ask" for FY 19 Read More Analysis and Commentary STEVEN GROSSMAN 4/13/18 Analysis and Commentary STEVEN GROSSMAN 4/13/18 CBER Today and Tomorrow: Challenges and Opportunities Read More Analysis and Commentary STEVEN GROSSMAN 4/6/18 Analysis and Commentary STEVEN GROSSMAN 4/6/18 A Hill Day Q&A ... Please Join Us Read More Analysis and Commentary STEVEN GROSSMAN 3/23/18 Analysis and Commentary STEVEN GROSSMAN 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More Analysis and Commentary STEVEN GROSSMAN 3/11/18 Analysis and Commentary STEVEN GROSSMAN 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More Analysis and Commentary STEVEN GROSSMAN 2/23/18 Analysis and Commentary STEVEN GROSSMAN 2/23/18 First Impressions and Key Priorities on the Hill Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 8/31/18 Analysis and Commentary STEVEN GROSSMAN 8/31/18 On the Physical Capabilities of a Lame Duck Read More
Analysis and Commentary STEVEN GROSSMAN 8/24/18 Analysis and Commentary STEVEN GROSSMAN 8/24/18 August as Usual in DC? Definitively NOT! Read More
Analysis and Commentary STEVEN GROSSMAN 8/5/18 Analysis and Commentary STEVEN GROSSMAN 8/5/18 The Full Senate Position on FDA's FY 19 Appropriation Read More
Analysis and Commentary STEVEN GROSSMAN 7/13/18 Analysis and Commentary STEVEN GROSSMAN 7/13/18 Our Advocacy Remains an Imperative for Strong Funding Read More
Analysis and Commentary STEVEN GROSSMAN 6/29/18 Analysis and Commentary STEVEN GROSSMAN 6/29/18 Aiming High AND Moving Quickly Read More
Analysis and Commentary STEVEN GROSSMAN 6/22/18 Analysis and Commentary STEVEN GROSSMAN 6/22/18 Good Fortune Can Easily Slip Away Read More
Analysis and Commentary STEVEN GROSSMAN 6/8/18 Analysis and Commentary STEVEN GROSSMAN 6/8/18 FY 19 Appropriations the Alliance Seeks to Support Read More
Analysis and Commentary STEVEN GROSSMAN 6/1/18 Analysis and Commentary STEVEN GROSSMAN 6/1/18 Strong BA Support for FDA on Capitol Hill -- At Different Levels Read More
Analysis and Commentary STEVEN GROSSMAN 5/24/18 Analysis and Commentary STEVEN GROSSMAN 5/24/18 FY 19 Funding: House and Senate Proposals Read More
Analysis and Commentary STEVEN GROSSMAN 5/17/18 Analysis and Commentary STEVEN GROSSMAN 5/17/18 House Recommends Major Increase in BA Funding Read More
Analysis and Commentary STEVEN GROSSMAN 5/11/18 Analysis and Commentary STEVEN GROSSMAN 5/11/18 The Good Start Continues ... Let's Show Appreciation Read More
Analysis and Commentary STEVEN GROSSMAN 5/4/18 Analysis and Commentary STEVEN GROSSMAN 5/4/18 Additional Investment = Substantial Added Value Read More
Analysis and Commentary STEVEN GROSSMAN 4/27/18 Analysis and Commentary STEVEN GROSSMAN 4/27/18 FY 19 -- Off to a Great Start Read More
Analysis and Commentary STEVEN GROSSMAN 4/21/18 Analysis and Commentary STEVEN GROSSMAN 4/21/18 The Alliance's "Ask" for FY 19 Read More
Analysis and Commentary STEVEN GROSSMAN 4/13/18 Analysis and Commentary STEVEN GROSSMAN 4/13/18 CBER Today and Tomorrow: Challenges and Opportunities Read More
Analysis and Commentary STEVEN GROSSMAN 4/6/18 Analysis and Commentary STEVEN GROSSMAN 4/6/18 A Hill Day Q&A ... Please Join Us Read More
Analysis and Commentary STEVEN GROSSMAN 3/23/18 Analysis and Commentary STEVEN GROSSMAN 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More
Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More
Analysis and Commentary STEVEN GROSSMAN 3/11/18 Analysis and Commentary STEVEN GROSSMAN 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More
Analysis and Commentary STEVEN GROSSMAN 2/23/18 Analysis and Commentary STEVEN GROSSMAN 2/23/18 First Impressions and Key Priorities on the Hill Read More
